New Risk • Apr 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Filipino stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.1% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₱672.9m market cap, or US$10.9m). Announcement • Apr 01
Medilines Distributors Incorporated, Annual General Meeting, Jun 24, 2026 Medilines Distributors Incorporated, Annual General Meeting, Jun 24, 2026. New Risk • Mar 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₱590.5m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.1% per year over the past 5 years. Market cap is less than US$10m (₱590.5m market cap, or US$9.92m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Nov 18
Third quarter 2025 earnings released: EPS: ₱0.001 (vs ₱0.02 loss in 3Q 2024) Third quarter 2025 results: EPS: ₱0.001 (up from ₱0.02 loss in 3Q 2024). Revenue: ₱281.8m (down 30% from 3Q 2024). Net income: ₱7.16m (up ₱72.0m from 3Q 2024). Profit margin: 2.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings. Recent Insider Transactions • Oct 08
Chairman of the Board recently bought ₱11m worth of stock On the 3rd of October, Virgilio Villar bought around 40m shares on-market at roughly ₱0.27 per share. This transaction amounted to 3.7% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱17m. Virgilio has been a buyer over the last 12 months, purchasing a net total of ₱32m worth in shares. Recent Insider Transactions • Sep 30
Chairman of the Board recently bought ₱17m worth of stock On the 26th of September, Virgilio Villar bought around 59m shares on-market at roughly ₱0.28 per share. This transaction amounted to 5.8% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Virgilio has been a buyer over the last 12 months, purchasing a net total of ₱21m worth in shares. Recent Insider Transactions • Sep 23
Chairman of the Board recently bought ₱3.4m worth of stock On the 18th of September, Virgilio Villar bought around 12m shares on-market at roughly ₱0.28 per share. This transaction amounted to 1.2% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Virgilio has been a buyer over the last 12 months, purchasing a net total of ₱4.4m worth in shares. New Risk • Aug 19
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 3.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₱755.3m market cap, or US$13.2m). Reported Earnings • Aug 15
Second quarter 2025 earnings released: ₱0.002 loss per share (vs ₱0.05 profit in 2Q 2024) Second quarter 2025 results: ₱0.002 loss per share (down from ₱0.05 profit in 2Q 2024). Revenue: ₱87.9m (down 66% from 2Q 2024). Net loss: ₱6.06m (down 104% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings. Declared Dividend • Jun 04
Dividend increased to ₱0.0094 Dividend of ₱0.0094 is 258% higher than last year. Ex-date: 1st July 2025 Payment date: 24th July 2025 Dividend yield will be 3.4%, which is higher than the industry average of 1.7%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 73%. Announcement • Jun 02
Medilines Distributors Incorporated Approves Declaration of Cash Dividends, Payable on 24 July 2025 The Board of Directors of Medilines Distributors Incorporated, during the Annual Stockholders' Meeting of company, held on 02 June 2025, approved the declaration of cash dividends equivalent to 20% of the Company's Net Income after Tax for the year ended 31 December 2024, equivalent to a total amount of PHP 25,948,637.00 or PHP 0.009447632 per share in favor of all its stockholders recorded as of 02 July 2025, payable on 24 July 2025. Reported Earnings • Apr 23
Full year 2024 earnings released: EPS: ₱0.047 (vs ₱0.026 in FY 2023) Full year 2024 results: EPS: ₱0.047 (up from ₱0.026 in FY 2023). Revenue: ₱1.42b (up 108% from FY 2023). Net income: ₱129.7m (up 79% from FY 2023). Profit margin: 9.2% (down from 11% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 29% per year, which means it is performing significantly worse than earnings. Announcement • Apr 14
Medilines Distributors Incorporated, Annual General Meeting, Jun 02, 2025 Medilines Distributors Incorporated, Annual General Meeting, Jun 02, 2025, at 10:00 W. Australia Standard Time. New Risk • Sep 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Filipino stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$100m (₱906.4m market cap, or US$16.0m). Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: ₱0.05 (vs ₱0 in 2Q 2023) Second quarter 2024 results: EPS: ₱0.05 (up from ₱0 in 2Q 2023). Revenue: ₱259.9m (up 87% from 2Q 2023). Net income: ₱136.6m (up ₱137.3m from 2Q 2023). Profit margin: 53% (up from net loss in 2Q 2023). The move to profitability was primarily driven by higher revenue. Declared Dividend • Jun 06
Dividend of ₱0.0026 announced Shareholders will receive a dividend of ₱0.0026. Ex-date: 2nd July 2024 Payment date: 26th July 2024 Dividend yield will be 0.9%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (28% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 31% per year over the past 2 years and payments have been stable during that time. The company's earnings per share (EPS) would need to decline by 69% to shift the payout ratio to a potentially unsustainable range, which is more than the 53% EPS decline seen over the last 5 years. New Risk • May 19
New major risk - Revenue and earnings growth Earnings have declined by 2.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.0% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₱851.4m market cap, or US$14.8m). Reported Earnings • Apr 27
Full year 2023 earnings released: EPS: ₱0.03 (vs ₱0.07 in FY 2022) Full year 2023 results: EPS: ₱0.03 (down from ₱0.07 in FY 2022). Revenue: ₱679.9m (down 65% from FY 2022). Net income: ₱72.5m (down 62% from FY 2022). Profit margin: 11% (in line with FY 2022). Announcement • Apr 16
Medilines Distributors Incorporated, Annual General Meeting, Jun 03, 2024 Medilines Distributors Incorporated, Annual General Meeting, Jun 03, 2024, at 10:00 Singapore Standard Time. New Risk • Apr 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Filipino stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (₱782.8m market cap, or US$13.8m). Reported Earnings • Nov 17
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: ₱124.4m (down 65% from 3Q 2022). Net income: ₱18.0m (down 42% from 3Q 2022). Profit margin: 14% (up from 8.8% in 3Q 2022). The increase in margin was driven by lower expenses. Reported Earnings • Aug 17
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: ₱139.3m (down 77% from 2Q 2022). Net loss: ₱693.5k (down 101% from profit in 2Q 2022). Upcoming Dividend • Jul 06
Upcoming dividend of ₱0.01 per share at 1.1% yield Eligible shareholders must have bought the stock before 13 July 2023. Payment date: 11 August 2023. Payout ratio is a comfortable 7.0% and the cash payout ratio is 88%. Trailing yield: 1.1%. Lower than top quartile of Filipino dividend payers (5.9%). Lower than average of industry peers (1.6%). Announcement • May 23
Medilines Distributors Incorporated, Annual General Meeting, Jul 03, 2023 Medilines Distributors Incorporated, Annual General Meeting, Jul 03, 2023. Reported Earnings • May 17
First quarter 2023 earnings released First quarter 2023 results: Revenue: ₱95.2m (down 63% from 1Q 2022). Net income: ₱5.67m (down 80% from 1Q 2022). Profit margin: 6.0% (down from 11% in 1Q 2022). The decrease in margin was driven by lower revenue. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Recent Insider Transactions • Nov 04
Chairman of the Board recently bought ₱1.6m worth of stock On the 2nd of November, Virgilio Villar bought around 2m shares on-market at roughly ₱0.82 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent buy, Virgilio has been a net seller over the last 12 months, reducing personal holdings by ₱631m. Announcement • Oct 20
Medilines Distributors Incorporated (PSE:MEDIC) announces an Equity Buyback for PHP 100 million worth of its shares. Medilines Distributors Incorporated (PSE:MEDIC) announces a share repurchase program. Under the program, the company will repurchase up to Php 100 million of share. The objectives of the share buyback program are to enhance shareholder value and to manifest confidence in the Company's value and prospects through the repurchase of the common shares of the Company. As of October 19, 2022, the company issued 2,750,000,800 shares. Announcement • Aug 18
Medilines Distributors Incorporated Approves the Declaration of Special Cash Dividend for the Second Quarter of 2022, Payable on September 22, 2022 Medilines Distributors Incorporated announced that the Board of Directors, in their Special Meeting on August 17, 2022, has approved the declaration of Special cash dividend equivalent to 5% of the Company's Net Income After Tax as of December 31, 2021, equivalent to PHP 0.0030842082 per share or a total amount of PHP 8,481,575 in favor of all its stockholders of record date as of September 1, 2022, payable on September 22, 2022. Reported Earnings • Aug 14
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: ₱595.0m (down 3.5% from 2Q 2021). Net income: ₱52.5m (down 43% from 2Q 2021). Profit margin: 8.8% (down from 15% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Announcement • Jul 13
Medilines Distributors Incorporated Announces Change of Corporate Secretary The board of directors of Medilines Distributors Incorporated at the special meeting held on July 13, 2022, Atty. Jo Marie Lazaro-Lim tendered her resignation as Corporate Secretary of the Company, effective immediately. Further, Mr. Daniel C. Zulueta has been appointed as her replacement. Daniel C. Zulueta, 59, graduated from the Far Eastern University with a degree in Bachelor of Arts in Economics. Prior to joining the Company, he held managerial positions in Operations and Business Development. Currently, he is also the General Manager of Medilines Distributors Incorporated and has been with the company for almost 13 years. Reported Earnings • May 29
First quarter 2022 earnings released First quarter 2022 results: Revenue: ₱259.9m (down 36% from 1Q 2021). Net income: ₱28.5m (down 44% from 1Q 2021). Profit margin: 11% (down from 13% in 1Q 2021). The decrease in margin was driven by lower revenue. Announcement • May 25
Medilines Distributors Incorporated Approves the Declaration of Cash Dividends for 2022, Payable on June 28, 2022 The Board of Directors of Medilines Distributors Incorporated, in their Special Meeting on 24 May 2022, has approved the declaration of cash dividends equivalent to 10% of the Company's Net Income After Tax as of December 31, 2021, equivalent to PHP 0.006168416 per share or total amount of PHP 16,963,150 in favor of all its stockholders of record as of June 7, 2022 payable on June 28, 2022. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Recent Insider Transactions • Dec 16
Chairman of the Board recently sold ₱633m worth of stock On the 7th of December, Virgilio Villar sold around 275m shares on-market at roughly ₱2.30 per share. This was the largest sale by an insider in the last 3 months. This was Virgilio's only on-market trade for the last 12 months. Announcement • Dec 08
Medilines Distributors Incorporated has completed an IPO in the amount of PHP 1.8975 billion. Medilines Distributors Incorporated has completed an IPO in the amount of PHP 1.8975 billion.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 825,000,000
Price\Range: PHP 2.3
Discount Per Security: PHP 0.06325 
